These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 15829009)

  • 21. [Factors associated with hepatic steatosis in human immunodeficiency virus and hepatits C virus coinfected patients].
    Pascual Pareja JF; Camino A; Larrauri J; López-Diéguez M; Montes ML; González-García J; Peña JM; Díez J; Arribas JR
    Med Clin (Barc); 2009 Feb; 132(6):208-13. PubMed ID: 19237003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prevalence and risk factors of hepatic steatosis in patients with chronic hepatitis B].
    Shi JP; Fan JG; Wu R; Gao XQ; Zhang L; Wang H
    Zhonghua Gan Zang Bing Za Zhi; 2008 Jul; 16(7):519-23. PubMed ID: 18647531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reliability of the bright liver echo pattern in diagnosing steatosis in patients with cryptogenic and HCV-related hypertransaminasaemia.
    Soresi M; Giannitrapani L; Florena AM; La Spada E; Di Gesaro V; Rappa F; Alessandri A; Tripi S; Romano M; Montalto G
    Clin Radiol; 2009 Dec; 64(12):1181-7. PubMed ID: 19913127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. More advanced hepatic fibrosis in hispanics with chronic hepatitis C infection: role of patient demographics, hepatic necroinflammation, and steatosis.
    Verma S; Bonacini M; Govindarajan S; Kanel G; Lindsay KL; Redeker A
    Am J Gastroenterol; 2006 Aug; 101(8):1817-23. PubMed ID: 16790034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic steatosis associated with hepatitis C virus infection.
    Cornianu M; Dema A; Tăban S; Lazăr D; Lazăr E; Costi S
    Rom J Morphol Embryol; 2005; 46(4):283-9. PubMed ID: 16688364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic steatosis in HIV/HCV co-infected patients: correlates, efficacy and outcomes of anti-HCV therapy: a paired liver biopsy study.
    Rodríguez-Torres M; Govindarajan S; Solá R; Clumeck N; Lissen E; Pessôa M; Buggisch P; Main J; Depamphilis J; Dieterich DT
    J Hepatol; 2008 May; 48(5):756-64. PubMed ID: 18314217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patients.
    McGovern BH; Ditelberg JS; Taylor LE; Gandhi RT; Christopoulos KA; Chapman S; Schwartzapfel B; Rindler E; Fiorino AM; Zaman MT; Sax PE; Graeme-Cook F; Hibberd PL
    Clin Infect Dis; 2006 Aug; 43(3):365-72. PubMed ID: 16804853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD.
    Ballestri S; Lonardo A; Romagnoli D; Carulli L; Losi L; Day CP; Loria P
    Liver Int; 2012 Sep; 32(8):1242-52. PubMed ID: 22520641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of steatosis on progression of fibrosis and virological response in chronic hepatitis C cases.
    Rafi H; Kabbaj N; Salihoun M; Amrani L; Acharki M; Guedira M; Nya M; Amrani N
    Arab J Gastroenterol; 2011 Sep; 12(3):136-8. PubMed ID: 22055591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases.
    Ballestri S; Nascimbeni F; Baldelli E; Marrazzo A; Romagnoli D; Targher G; Lonardo A
    Metabolism; 2017 Jul; 72():57-65. PubMed ID: 28641784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic steatosis correlates with the postoperative recurrence of hepatitis C virus-associated hepatocellular carcinoma.
    Takuma Y; Nouso K; Makino Y; Saito S; Takayama H; Takahara M; Takahashi H; Murakami I; Takeuchi H
    Liver Int; 2007 Jun; 27(5):620-6. PubMed ID: 17498246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease.
    Masarone M; La Mura V; Bruno S; Gaeta GB; Vecchione R; Carrino F; Moschella F; Torella R; Persico M
    J Viral Hepat; 2007 Oct; 14(10):714-20. PubMed ID: 17875006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive factors for the severity of liver fibrosis in patients with chronic hepatitis C and moderate alcohol consumption.
    Vădan R; Gheorghe L; Becheanu G; Iacob R; Iacob S; Gheorghe C
    Rom J Gastroenterol; 2003 Sep; 12(3):183-7. PubMed ID: 14502317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic steatosis and fibrosis in chronic hepatitis C in Taiwan.
    Hsieh MH; Lee LP; Hsieh MY; Tsai KB; Huang JF; Hou NJ; Chen SC; Lin ZY; Hsieh MY; Wang LY; Dai CY; Chuang WL; Yu ML
    Jpn J Infect Dis; 2007 Nov; 60(6):377-81. PubMed ID: 18032828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sonographic hepatorenal ratio: a noninvasive method to diagnose nonalcoholic steatosis.
    Borges VF; Diniz AL; Cotrim HP; Rocha HL; Andrade NB
    J Clin Ultrasound; 2013 Jan; 41(1):18-25. PubMed ID: 22997020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic steatosis: correlations of body mass index, CT fat measurements, and liver density with biopsy results.
    Gaba RC; Knuttinen MG; Brodsky TR; Palestrant S; Omene BO; Owens CA; Bui JT
    Diagn Interv Radiol; 2012; 18(3):282-7. PubMed ID: 22258794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistently normal alanine aminotransferase levels in HIV/HCV-coinfected patients: the role of steatosis.
    Bani-Sadr F; Barange K; Daoud F; Jacomet C; Bicart-See A; Rosenthal E; Cacoub P; Pol S; Perronne C; Carrat F;
    HIV Med; 2009 Aug; 10(7):417-21. PubMed ID: 19490173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.
    Burra P; Loreno M; Russo FP; Germani G; Galligioni A; Senzolo M; Cillo U; Zanus G; Fagiuoli S; Rugge M
    Liver Transpl; 2009 Jun; 15(6):619-28. PubMed ID: 19479805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of steatosis on progression of fibrosis in patients with mild hepatitis C.
    Fartoux L; Chazouillères O; Wendum D; Poupon R; Serfaty L
    Hepatology; 2005 Jan; 41(1):82-7. PubMed ID: 15690484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Steatosis in chronic hepatitis B: prevalence and correlation with biochemical, histologic, viral, and metabolic parameters.
    Rastogi A; Sakhuja P; Kumar A; Hissar S; Jain A; Gondal R; Sarin SK
    Indian J Pathol Microbiol; 2011; 54(3):454-9. PubMed ID: 21934202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.